Stereotactic Radiosurgery for limited brain metastasis using different techiniques, Helical Tomotherapy, Volumetric Modulated Arc Therapy and Cone-based Linac radiosurgery

Not Applicable

Completed

• Conditions: Patients with known primary cancer who develop limited brain metastasis (less than 4 lesions) and received stereotactic radiosurgery will be enrolled to this study; stereotactic radiosurgery, Helical Tomotherapy (HT), Volumetric Arc Therapy (VMAT), Cone- based Linac radiosurgery (cone- based)

• Registration Number: TCTR20200803006
• Lead Sponsor: Faculty of Medicine, Chiang Mai University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2019-10-31
• Study Start: 2020-08-03
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 21

Inclusion Criteria

1.age 18 to 70 years old
2.known primary cancer
3.evidence of limited brain metastasis (less than 4 lesions)
4.ECOG 0-2

Exclusion Criteria

1.history of previous cranial irradiation
2.evidence of leptomeningeal dissemination

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Dosimetric comparison of radiotherapy planning re-planing of stereotactic radiosurgery for limited brain metastasis radiotherapy planning

Secondary Outcome Measures

Name	Time	Method
6-month intracranial tumor control after stereotactic radiosurgery serial cranial MRI